Late-onset Erythropoietic Protoporphyria Associated with Myelodysplastic Syndrome Treated with Azacitidine

被引：3
|
作者：
Yoshioka, Ai [1 ]
Fujiwara, Susumu [1 ]
Kawano, Hiroki [2 ]
Nakano, Hajime [3 ]
Taketani, Shigeru [4 ]
Matsui, Toshimitsu [5 ]
Katayama, Yoshio [2 ]
Nishigori, Chikako [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Dermatol, 5-2,Kusunoki Cho7, Kobe, Hyougo 6500017, Japan
[2] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Hematol, 5-2,Kusunoki Cho7, Kobe, Hyougo 6500017, Japan
[3] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan
[4] Kansai Med Univ, Dept Microbiol, Hirakata, Osaka, Japan
[5] Nishiwaki Municipal Hosp, Dept Haematol, Nishiwaki, Japan
来源：
ACTA DERMATO-VENEREOLOGICA | 2018年 / 98卷 / 02期
关键词：
SIDEROBLASTIC ANEMIA; ERYTHROCYTE PROTOPORPHYRIN; DERMAL PHOTOSENSITIVITY; RINGED SIDEROBLASTS;
D O I：
10.2340/00015555-2829
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：275 / 277
页数：3
相关论文
共 50 条
  • [21] Myelodysplastic syndrome terminating in erythropoietic protoporphyria after 15 years of aplastic anemia
    Shirota, T
    Yamamoto, H
    Hayashi, S
    Fujimoto, H
    Harada, Y
    Hayashi, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 72 (01) : 44 - 47
  • [22] Late-Onset Bartter Syndrome
    Alex, Mica
    Elharrif, Khalid
    Al-Taweel, Omar S.
    Greti, Petersen
    Kassem, Hania
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 369 - 370
  • [23] Recovery from acute cholestasis associated with erythropoietic protoporphyria treated by antibiotics
    Asada, N
    Kitamoto, M
    Aisaka, Y
    Kawamura, H
    Nakanishi, T
    Kajiyama, G
    Horie, Y
    CLINICA CHIMICA ACTA, 1999, 282 (1-2) : 197 - 201
  • [24] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Kataoka, Asami
    Mizumoto, Chisaki
    Kanda, Junya
    Iwasaki, Makoto
    Sakurada, Maki
    Oka, Tomomi
    Fujimoto, Masakazu
    Yamamoto, Yosuke
    Yamashita, Kohei
    Nannya, Yasuhito
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (06) : 919 - 924
  • [25] Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome
    Asami Kataoka
    Chisaki Mizumoto
    Junya Kanda
    Makoto Iwasaki
    Maki Sakurada
    Tomomi Oka
    Masakazu Fujimoto
    Yosuke Yamamoto
    Kohei Yamashita
    Yasuhito Nannya
    Seishi Ogawa
    Akifumi Takaori-Kondo
    International Journal of Hematology, 2023, 117 : 919 - 924
  • [26] Annular Elastolytic Giant Cell Granuloma Associated to Late-Onset X-Linked Dominant Protoporphyria
    Javier Garcia-Martinez, Francisco
    Gutierrez-Gonzalez, Enrique
    Alonso-Gonzalez, Julio
    Vega, Ana
    Santamarina, Marta
    Teresa Rodriguez-Granados, Maria
    Toribio, Jaime
    DERMATOLOGY, 2013, 227 (03) : 238 - 242
  • [27] Eosinophilic Pneumonia Associated With Azacitidine in a Patient With Myelodysplastic Syndrome
    Nair, Girish B.
    Charles, Melissa
    Ogden, Lorna
    Spiegler, Peter
    RESPIRATORY CARE, 2012, 57 (04) : 631 - 633
  • [28] Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine
    Borthakur, Gautam
    El Ahdab, Samih
    Ravandi, Farhad
    Faderl, Stefan
    Ferrajoli, Alessandra
    Newman, Beth
    Issa, Jean-Pierre
    Kantarjian, Hagop
    LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 690 - 695
  • [29] Necrotizing fasciitis in two patients with myelodysplastic syndrome treated with azacitidine
    Lai, Shiue-Wei
    Huang, Tzu-Chuan
    Ye, Ren-Hua
    Wu, Yi-Ying
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 273 - 276
  • [30] Usher syndrome and late-onset psychosis
    Gupta, Arun
    Bastiampillai, Tarun
    AUSTRALASIAN PSYCHIATRY, 2017, 25 (03) : 316 - 316
12345